Different specificities of SLE-derived and therapy-induced interferon-alpha antibodies.
Nolte
K U
KU
Department of Immunology and Transfusion Medicine, Hannover Medical School, Germany.
Jakschies
D
D
Pestka
S
S
Von Wussow
P
P
D000917:Antibody Formation; D000918:Antibody Specificity; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000276:immunology / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins